Sugi Predict

Sugi Predict / Compounds / SCHEMBL623148

SCHEMBL623148

SCHEMBL623148

c1ccc(-c2ccccc2-c2cccc3ccccc23)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 1/20 0.52
▸ ALDH1A1 P00352 5/20 0.52
▸ TSHR P16473 4/20 0.52
▸ HSD17B10 Q99714 4/20 0.52
▸ L3MBTL1 Q9Y468 4/20 0.52
▸ HPGD P15428 3/20 0.52
▸ MAPT P10636 3/20 0.52
▸ MAPK1 P28482 3/20 0.52
▸ TDP1 Q9NUW8 3/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ ATM Q13315 2/20 0.52
▸ TP53 P04637 1/20 0.52
▸ NFKB1 P19838 1/20 0.52
▸ NFKB2 Q00653 1/20 0.52
▸ RELA Q04206 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ MPI P34949 1/20 0.50
▸ CA12 O43570 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29732781 1.00 TNF (0.52) TNFALDH1A1TSHRHSD17B10L3MBTL1
SCHEMBL29463735 1.00 TNF (0.52) TNFALDH1A1TSHRHSD17B10L3MBTL1
SCHEMBL867854 1.00 TNF (0.52) TNFALDH1A1TSHRHSD17B10L3MBTL1
Hydrogen Sulfide SCHEMBL27664397 0.98 ALDH1A1 (0.50) TNFALDH1A1TSHRHSD17B10L3MBTL1
Ammonia Solution, Strong SCHEMBL5778906 0.98 ALDH1A1 (0.50) TNFALDH1A1TSHRHSD17B10L3MBTL1
SCHEMBL9313726 0.98 ALDH1A1 (0.50) TNFALDH1A1TSHRHSD17B10L3MBTL1
Ammonia Solution, Strong SCHEMBL1552163 0.98 ALDH1A1 (0.50) TNFALDH1A1TSHRHSD17B10L3MBTL1
SCHEMBL27664395 0.98 ALDH1A1 (0.50) TNFALDH1A1TSHRHSD17B10L3MBTL1
SCHEMBL28364735 0.96 CA12 (0.49) TNFALDH1A1TSHRHSD17B10L3MBTL1
Water SCHEMBL27984347 0.96 ALDH1A1 (0.49) TNFALDH1A1TSHRHSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114728947-B Compound and organic light emitting device using the same 株式会社LG化学 2024-09-06 — — CN claimed
CN-113557229-B Novel compound and organic light emitting device comprising the same 株式会社LG化学 2024-08-02 — — CN claimed
CN-116746296-A Organic light emitting device 株式会社LG化学 2023-09-12 — — CN claimed
CN-116724677-A Organic light emitting device 株式会社LG化学 2023-09-08 — — CN claimed
CN-116671280-A Organic light emitting device 株式会社LG化学 2023-08-29 — — CN claimed
CN-111326665-B New material and electroluminescent device thereof 固安鼎材科技有限公司 2023-08-22 — — CN claimed
CN-114728947-A Novel compound and organic light emitting device using the same 株式会社LG化学 2022-07-08 — — CN claimed
CN-113557229-A Novel compound and organic light emitting device comprising same 株式会社LG化学 2021-10-26 — — CN claimed
WO-2021162227-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME 주식회사 엘지화학 2021-08-19 — — WO claimed
US-20200274077-A1 PHOTOELECTRIC CONVERSION ELEMENT AND IMAGING APPARATUS SONY CORPORATION (JP) 2020-08-27 — — US claimed
US-9115159-B2 Phosphate compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2015-08-25 — — US claimed
EP-2603479-A2 ELECTROACTIVE COMPOUND AND COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION E.I. Du Pont De Nemours And Company (US) 2013-06-19 — — EP claimed
US-20120187383-A1 ELECTROACTIVE COMPOUND AND COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION E.I. DU PONT DE NEMOURS AND COMPANY (US) 2012-07-26 — — US claimed
WO-2012021315-A2 ELECTROACTIVE COMPOUND AND COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-02-16 — — WO claimed
EP-2220702-B1 DEVICE COMPRISING AN ORGANIC COMPONENT AND AN ENCAPSULATION LAYER WITH A MOISTURE-REACTIVE MATERIAL COMMISSARIAT ENERGIE ATOMIQUE (FR) 2011-09-28 — — EP claimed
US-7696374-B2 Arylalklcarbamate derivatives, preparation method thereof and use of same in therapeutics SANOFI-AVENTIS (FR) 2010-04-13 — — US claimed
CN-101535241-A Phenyloxyaniline derivatives BAYER SCHERING PHARMA AG (DE) 2009-09-16 — — CN claimed
US-20080160342-A1 HOST COMPOSITIONS FOR LUMINESCENT MATERIALS E. I. DU PONT DE NEMOURS AND COMPANY 2008-07-03 — — US claimed
US-6964795-B2 Multilayer optical compensator, liquid crystal display, and process EASTMAN KODAK COMPANY (US) 2005-11-15 — — US claimed
US-4801703-A PHOSPHORUS COMPOUNDS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1989-01-31 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120187383-A1 ELECTROACTIVE COMPOUND AND COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE COMPOSITION CCNL2, ESR1, ESR2 TNF 4883/4885ALDH1A1 523/4885TSHR 3717/4885
US-20200274077-A1 PHOTOELECTRIC CONVERSION ELEMENT AND IMAGING APPARATUS PPOX, JUP, L1CAM TNF 4868/4885ALDH1A1 2007/4885TSHR 3758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.